Establishment of Pharmaceutical Care Pathway for Tumor Patients Treated by Integrative Traditional Chinese and Western Medicine

CHEN Wen; MOU Jizheng; SA Rina; WANG Xiaoyang; WANG Lixia

doi:10.14009/j.issn.1672-2124.2020.05.031

您当前的位置：

首页 >

文章列表页 >

Establishment of Pharmaceutical Care Pathway for Tumor Patients Treated by Integrative Traditional Chinese and Western Medicine

更新时间：2022-10-08

- Establishment of Pharmaceutical Care Pathway for Tumor Patients Treated by Integrative Traditional Chinese and Western Medicine
- Vol. 20, Issue 5, Pages: 628-630(2020)
- 作者机构：
  
  1. 中国中医科学院广安门医院药剂科
  2. 甘肃省人民医院药剂科
  3. 辽宁中医药大学附属医院药剂科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.05.031
  CLC： R969
- Published：2020，
扫描看全文
[1]陈雯,牟稷征,萨日娜,王晓阳,王丽霞.中西医结合治疗肿瘤患者药学监护路径的构建[J].中国医院用药评价与分析,2020,20(05):628-630+635.

CHEN Wen, MOU Jizheng, SA Rina, et al. Establishment of Pharmaceutical Care Pathway for Tumor Patients Treated by Integrative Traditional Chinese and Western Medicine. [J]. 20(5):628-630(2020)
[1]陈雯,牟稷征,萨日娜,王晓阳,王丽霞.中西医结合治疗肿瘤患者药学监护路径的构建[J].中国医院用药评价与分析,2020,20(05):628-630+635. DOI： 10.14009/j.issn.1672-2124.2020.05.031.

CHEN Wen, MOU Jizheng, SA Rina, et al. Establishment of Pharmaceutical Care Pathway for Tumor Patients Treated by Integrative Traditional Chinese and Western Medicine. [J]. 20(5):628-630(2020) DOI： 10.14009/j.issn.1672-2124.2020.05.031.

摘要

目的:为中药临床药师规范开展药学监护提供新思路。方法:构建中西医结合治疗肿瘤患者药学监护路径

以"药学监护路径表"为指导

对患者进行分阶段的药学监护

并确定监护重点内容及对策。结果:临床药师以药学监护路径为导向

快速、规范和有针对性地对中西医结合治疗的肿瘤患者开展个体化的药学监护工作

同时不断将新的药学信息和临床证据引入到药学监护路径中

使其内容更加完善。结论:药学监护路径的构建

有助于临床药学工作的顺利开展。

Abstract

OBJECTIVE: To provide new idea for the clinical pharmacists of traditional Chinese medicine to standardize the development of pharmaceutical care. METHODS:The pharmaceutical care pathway of integrated traditional Chinese and western medicine treatment for tumor patients was constructed

and the patients were given pharmaceutical care in stages under the Guidance of Pharmaceutical Care Pathway Table

and the key contents and countermeasures of the pharmaceutical care were determined. RESULTS: According to the guidance of pharmaceutical care pathway

clinical pharmacists rapidly

normatively and pertinently carried out individualized pharmaceutical care for tumor patients treated by integrated traditional Chinese and western medicine

and continuously introduced new pharmaceutical information and clinical evidence into the pharmaceutical care pathway

so as to improve the content.CONCLUSIONS: The construction of pharmaceutical care pathway is conducive to the smooth development of clinical pharmaceutical work.

关键词

临床药师恶性肿瘤中西医结合药学监护路径

Keywords

Clinical pharmacistsMalignant tumorsIntegration of traditional Chinese and western medicinePharmaceutical care pathway

references

查看原文

Views

104

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Consultation Analysis on 174 Cases of Intra-Abdominal Infection by Clinical Pharmacists

Effectiveness of Participation of Pharmacists in Pain Management of Knee Replacement Under Accelerated Rehabilitation

Effect Evaluation of Intervention on Potentially Inappropriate Medication in Elderly Inpatients by Clinical Pharmacists

Drug Use in 2 392 Oncology Medical Records Based on PCNE Classification

A Randomized Controlled Study of Pharmaceutical Intervention on Patients with Peptic Ulcer and Helicobacter Pylori Infection by Clinical Pharmacists

Related Author

ZHANG Yang

CHENG Sheng

LUO Xiao

WEN Aiping

LIAO Yin

GUO Heng

ZHANG Chao

LI Dandan

Related Institution

Dept. of Pharmacy, Beijing Friendship Hospital, Capital Medical University

Dept. of Orthopedics, Baoding No.1 Central Hospital

Dept. of Pharmacy, Baoding No.1 Central Hospital

Institute of Clinical Pharmacology, Peking University First Hospital

Dept.of Pharmacy, Peking University First Hospital

⁰